Publicacións en colaboración con investigadores/as de Complexo Hospitalario Universitario de Vigo (11)

2022

  1. Insulin-like Growth Factor 2 (IGF-2) and Insulin-like Growth Factor Binding Protein 7 (IGFBP-7) Are Upregulated after Atypical Antipsychotics in Spanish Schizophrenia Patients

    International Journal of Molecular Sciences, Vol. 23, Núm. 17

2021

  1. Humanization in mental health plans in Spain

    Revista de Psiquiatria y Salud Mental

  2. Predictors of persistence in patients with schizophrenia treated with aripiprazole once-monthly long-acting injection in the Spanish clinical practice: a retrospective, observational study

    European psychiatry : the journal of the Association of European Psychiatrists, Vol. 64, Núm. 1, pp. e40

2019

  1. Improving emotion recognition in schizophrenia with “VOICES”: An on-line prosodic self-training

    PLoS ONE, Vol. 14, Núm. 1

2018

  1. Serotonin syndrome versus neuroleptic malignant syndrome: a case report

    Actas Espanolas de Psiquiatria

  2. The role of the gut microbiota in schizophrenia: Current and future perspectives

    World Journal of Biological Psychiatry, Vol. 19, Núm. 8, pp. 571-585

2017

  1. Influence of depressive symptoms on distress related to positive psychotic-like experiences in women

    Psychiatry Research, Vol. 258, pp. 469-475

2013

  1. Testing a virtual reality intervention for pain control

    European Journal of Pain (United Kingdom), Vol. 17, Núm. 9, pp. 1403-1410

2012

  1. Serotonin transporter clustering in blood lymphocytes as a putative biomarker of therapeutic efficacy in major depressive disorder

    Journal of Affective Disorders, Vol. 137, Núm. 1-3, pp. 46-55

2011

  1. Comparison of long-acting antipsychotic injection and oral antipsychotics in schizophrenia

    Neuropsychiatry, Vol. 1, Núm. 3, pp. 275-289

2010

  1. Estudio longitudinal comparativo entre pacientes con y sin exacerbación premenstrual de la depresin

    Revista de Psiquiatria y Salud Mental, Vol. 3, Núm. 3, pp. 97-101